Phase 2 Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older.
- People who have been diagnosed with breast cancer that has spread locally or to other parts of the body, confirmed through a tissue or cell sample test.
- People whose cancer is hormone receptor (HR) positive, meaning the cancer cells show at least 1% presence of estrogen and/or progesterone receptors on testing.
- People whose cancer is HER2-negative, as determined by established testing guidelines.
- People who have at least one measurable area of cancer outside the brain, as defined by standard measurement criteria.
- People who have a good general level of physical functioning (able to carry out daily activities with little or no restriction).
- People whose cancer has previously gotten worse while being treated with a specific type of targeted therapy (CDK4/6 inhibitor) combined with hormone-based treatment.
- People who have adequate functioning of their organs and heart, as confirmed by testing.
- People who have gone through menopause naturally, or people who have not yet gone through menopause but are receiving treatment to suppress ovarian function.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have cancer that has spread to the brain and is currently active or has not yet been treated.
- People who have previously been treated with a specific type of drug known as an antibody-drug conjugate (ADC) that carries a topoisomerase I inhibitor as its active component.
- People who currently have active lung inflammation or scarring of the lung tissue.
- People who have poorly controlled heart or blood vessel disease, or a currently active infection.
- People who have had another cancer diagnosed within the past 5 years (though certain exceptions may apply — confirm with trial site).
- People who are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-512-62850800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of dose-limiting toxicities (DLTs); Objective Response Rate (ORR); Safety and tolerability (TEAEs, TRAEs, SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.